Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aroa Biosurgery
Auckland, New Zealandaroa.com ↗
- Ownership
- Public · ARX
- Development stage
- Other
01
Overview
Aroa Biosurgery has commercialized multiple soft-tissue regenerative products based on its proprietary extracellular matrix technology. Its products have been used in over four million procedures globally with regulatory approvals in nearly fifty countries. Clinical data support improved healing rates and outcomes in complex wound care and surgical applications at a lower cost compared to human-derived or synthetic alternatives.
- Therapeutic areas
- DermatologyWomen's HealthOther
- Modalities
- DeviceBiologic
- Industry
- Therapeutic Medical Devices
02
Partnerships
Tela Bio – licensing partner for OviTex reinforced bioscaffold products for hernia and breast surgery in the US market
Beyond the preview
Go deeper on Aroa Biosurgery.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aroa Biosurgery.